Biofilm Formation on Dental Implant Biomaterials by Staphylococcus aureus Strains Isolated from Patients with Cystic Fibrosis.
Anna Minkiewicz-ZochniakSylwia JarzynkaAgnieszka IwańskaKamila StromBartłomiej IwańczykMarta BartelMaciej MazurAnna Pietruczuk-PadzikMałgorzata KoniecznaEwa Augustynowicz-KopećGabriela OledzkaPublished in: Materials (Basel, Switzerland) (2021)
Implants made of ceramic and metallic elements, which are used in dentistry, may either promote or hinder the colonization and adhesion of bacteria to the surface of the biomaterial to varying degrees. The increased interest in the use of dental implants, especially in patients with chronic systemic diseases such as cystic fibrosis (CF), is caused by an increase in disease complications. In this study, we evaluated the differences in the in vitro biofilm formation on the surface of biomaterials commonly used in dentistry (Ti-6Al-4V, cobalt-chromium alloy (CoCr), and zirconia) by Staphylococcus aureus isolated from patients with CF. We demonstrated that S. aureus adherence and growth depends on the type of material used and its surface topography. Weaker bacterial biofilm formation was observed on zirconia surfaces compared to titanium and cobalt-chromium alloy surfaces. Moreover, scanning electron microscopy showed clear differences in bacterial aggregation, depending on the type of biomaterial used. Over the past several decades, S. aureus strains have developed several mechanisms of resistance, especially in patients on chronic antibiotic treatment such as CF. Therefore, the selection of an appropriate implant biomaterial with limited microorganism adhesion characteristics can affect the occurrence and progression of oral cavity infections, particularly in patients with chronic systemic diseases.
Keyphrases
- reduced graphene oxide
- biofilm formation
- cystic fibrosis
- pseudomonas aeruginosa
- staphylococcus aureus
- electron microscopy
- tissue engineering
- escherichia coli
- lung function
- candida albicans
- end stage renal disease
- ejection fraction
- soft tissue
- newly diagnosed
- chronic kidney disease
- risk assessment
- peritoneal dialysis
- oral health
- bone regeneration
- patient reported outcomes
- insulin resistance
- adipose tissue
- glycemic control
- replacement therapy
- metal organic framework